生物医药迎IPO热潮,18A政策下港股能否成融资“避风港”?

21世纪经济报道
Sep 18

港股市场再度成为生物医药企业的“融资港湾”,据21世纪经济报道记者不完全统计,2025年以来已有13家内地生物科技公司成功登陆港股,这一数字已超去年全年总和。  9月,港股IPO市场迎来一波生物医药企业上市热潮。9月17日,数字医疗服务平台健康160历经三次递表后成功在港交所主板上市,开盘大涨154.84%,报30.30港元/股,市值101.95亿港元。  与此同时,三家创新药企也加速推进港股上市...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10